Clinical trial
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
NCT00375258 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00375258 |
|---|---|
| Title | Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage |
| Official title | A Large Randomised Placebo Controlled Trial Among Trauma Patients With, or at Risk of, Significant Haemorrhage, of the Effects of Antifibrinolytic Treatment on Death and Transfusion Requirement |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemorrhage |
| Intervention type | Drug |
| Interventions | Tranexamic acid, Sodium Chloride 0.9% |
| Enrollment | 20,211 |
| Start date | May 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 12, 2006 |
| Last update posted | Jun 30, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: